Novel lactic acid bacteria having immunoregulatory activities derived from human digestive tract and use thereof

摘要

The specific Lactobacillus sp. Strain, the Bifidobacterium sp. Strain, the specific Streptococcus sp. Strain or the specific Colinella spp. Strain according to the present invention is isolated from human feces and has high safety, and has immunity control effect, immunity enhancement effect, , Anti-inflammatory efficacy, colitis improving effect, arthritis improving efficacy, anti-obesity efficacy, anti-stress efficacy, anti-anxiety efficacy, antidepressant efficacy or anti-schizophrenic efficacy. The specific Lactobacillus sp. Strain, the Bifidobacterium sp. Strain, the specific Streptococcus sp. Strain or the specific Colinella spp. Strain according to the present invention may be used as a material for immunomodulation, immunity enhancement, inflammation suppression and stress relaxation, It can also be used as a functional food material useful for preventing, improving or treating allergic diseases, inflammatory diseases, colitis, arthritis, obesity, anxiety disorder, depression or schizophrenia.